NDC 69097-516 – Cyclophosphamide
Cyclophosphamide 25 mg/1 · Capsule · Oral
Product NDC69097-516
Product details
- Brand name
- Cyclophosphamide
- Generic name
- Cyclophosphamide
- Labeler
- Cipla USA Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA211608
- Marketed since
- January 18, 2019
- Listing expires
- December 31, 2026
Active ingredients
- Cyclophosphamide 25 mg/1
Uses, dosage, side effects and warnings for Cyclophosphamide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69097-516-07 | 100 CAPSULE in 1 BOTTLE (69097-516-07) | Jan 18, 2019 |
Other Cyclophosphamide products
- 62332-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 69097-517 Cyclophosphamide 50 mg/1 · Capsule · Cipla USA Inc.
- 0054-0382 Cyclophosphamide 25 mg/1 · Capsule · Hikma Pharmaceuticals USA Inc.
- 0054-0383 Cyclophosphamide 50 mg/1 · Capsule · Hikma Pharmaceuticals USA Inc.
- 70301-2015 Cyclophosphamide 50 mg/1 · Capsule · OPKO Pharmaceuticals, LLC
- 70301-2013 Cyclophosphamide 25 mg/1 · Capsule · OPKO Pharmaceuticals, LLC
- 70121-1238 Cyclophosphamide 500 mg/25mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1240 Cyclophosphamide 2 g/100mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1239 Cyclophosphamide 1 g/50mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC